VenatoRx Pharmaceuticals, Inc.

DelveInsight's report on Complicated Urinary Tract Infection (UTI) clinical trials highlights 12+ companies developing 12+ pipeline drugs, with therapies in various stages of development, including Phase III. Key companies include Spero Therapeutics, Iterum Therapeutics, Venatorx Pharmaceuticals, Nabriva Therapeutics, Allecra Therapeutics, Wockhardt, and MerLion Pharmaceuticals.